Our results indicated that NExT bind to PDL1 on tumor cells and reduce their availability (Fig. 3i), suggesting that NExT could elicit a PDL1 occupancy that would block PD1/PDL1 interaction between T-lymphocytes and tumors. The gene discussed is CD274; the disease is neoplasm.